Found 473 articles for: "atopic dermatitis"
Topical Pimecrolimus 1% Reverses Long-term Suberythemal Ultraviolet B—induced Epidermal Langerhans Cell Reduction and Morphologic Changes in Mice
September 2012 | Volume 11 | Issue 9 | Original Article | 25 | Copyright © September 2012
Objective: Some literature reported that topical calcineurin inhibitors (TCIs) did not accelerate photocarcinogenesis in hairless mice after long-term simulated solar radiation. In this work, w...
Read MoreAdjunctive Use of a Facial Moisturizer SPF 30 Containing Ceramide Precursor Improves Tolerability of Topical Tretinoin 0.05%: A Randomized, Investigator-Blinded, Split-Face Study
September 2012 | Volume 11 | Issue 9 | Original Article | 1104 | Copyright © September 2012
Objectives: To assess the benefit of adjunctive use of a SPF 30 moisturizing lotion in reducing local side effects associated with atopical tretinoin cream.
Methods:This was a rand...
Read MoreCLINICAL TRIAL REVIEW
August 2012 | Volume 11 | Issue 8 | Features | 1012 | Copyright © August 2012
Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoing clinical testing. It is our goal to inform the reader of the status of select ...
Read MoreUstekinumab for Treatment of Plaque Psoriasis in a Patient With Down Syndrome
August 2012 | Volume 11 | Issue 8 | Case Reports | 1000 | Copyright © August 2012
Down syndrome (DS) is the most common chromosomal disorder and a major cause of mental retardation. Down syndrome phenotype is complex and may present a combination of dysmorphic features, congenital ...
Read MoreThe Use of Cyclosporine in Dermatology
August 2012 | Volume 11 | Issue 8 | Original Article | 979 | Copyright © August 2012
Cyclosporine is an immunosuppressive drug that acts selectively on T-cells by inhibiting calcineurin phosphorylase. It has been used in dermatology since its approval for US Food and Drug Administrati...
Read MoreThe Safety of Ustekinumab in Psoriasis
August 2012 | Volume 11 | Issue 8 | Original Article | 907 | Copyright © August 2012
Ustekinumab is effective in the treatment of a variety of autoimmune conditions including psoriasis. As a relatively new therapeutic agent, its long-term effects are still under investigation. Short-t...
Read MoreClinical Trial Review
July 2012 | Volume 11 | Issue 7 | Features | 888 | Copyright © July 2012
Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoing clinical testing. It is our goal to inform the reader of the status of select...
Read MoreNews, Views, & Reviews
The Outer Aspect of Our Inner Anxiety: The Skinny on StressJuly 2012 | Volume 11 | Issue 7 | Features | 883 | Copyright © July 2012
Effective Topical Combination Therapy for Treatment of Lichen Striatus in Children: A Case Series and Review
July 2012 | Volume 11 | Issue 7 | Case Reports | 872 | Copyright © July 2012
Lichen striatus (LS) is an uncommon linear dermatosis that is primarily seen in children from 4 months to 15 years of age. While some of these eruptions are asymptomatic, others can be quite pruritic....
Read MoreCombined Antibiotic/Corticosteroid Cream in the Empirical Treatment of Moderate to Severe Eczema: Friend or Foe?
July 2012 | Volume 11 | Issue 7 | Original Article | 861 | Copyright © July 2012
Background: Eczema is a common atopic disease associated with pruritus, sleep disturbance, ...
Read MoreEfficacy and Tolerability of Retapamulin 1% Ointment for the Treatment of Infected Atopic Dermatitis: A Pilot Study
July 2012 | Volume 11 | Issue 7 | Original Article | 858 | Copyright © July 2012
Background: Patients with atopic dermatitis (AD) are known to have a predisposition to colonization or infection by microbial organisms, including both Staphylococcus aureus and herpes simplex...
Read MoreColloidal Oatmeal Formulations as Adjunct Treatments in Atopic Dermatitis
July 2012 | Volume 11 | Issue 7 | Original Article | 804 | Copyright © July 2012
Colloidal oatmeal has been used for decades to soothe and ameliorate atopic dermatitis and other pruritic and/or xerotic dermatoses. In-vitro and/or in-vivo studies have confirmed the anti-inflammato...
Read MoreMessage from the Guest Editor
July 2012 | Volume 11 | Issue 7 | Editorials | 803 | Copyright © July 2012
Safety and Efficacy of Two Anti-Acne/Anti-Aging Treatments in Subjects With Photodamaged Skin and Mild to Moderate Acne Vulgaris
June 2012 | Volume 11 | Issue 6 | Original Article | 737 | Copyright © June 2012
Background: Although reliable prevalence data are not available, adult acne is thought to be somewhat common, and...
Read MoreCLINICAL TRIAL REVIEW
May 2012 | Volume 11 | Issue 5 | Features | 671 | Copyright © May 2012
Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoing clinical testing. It is our goal to inform the reader of the status of select...
Read MoreRESIDENT ROUNDS: PART I
Program Spotlight: Department of Dermatology,Oregon Health & Science UniversityMay 2012 | Volume 11 | Issue 5 | Features | 653 | Copyright © May 2012
Resident Rounds is a section of the JDD dedicated to highlighting various dermatology departments with residency training programs. Resident Rounds includes three sections: (1) a program spotlight, h...
Read MoreBiophysical Evaluation of Fractional Laser Skin Resurfacing With an Er:YSGG Laser Device in Japanese Skin
May 2012 | Volume 11 | Issue 5 | Original Article | 637 | Copyright © May 2012
Background: Ablative fractional laser skin resurfacing (FLSR) has recently been used for the ameliorati...
Read MoreA Comparison of Physicochemical Properties of a Selection of Modern Moisturizers: Hydrophilic Index and pH
May 2012 | Volume 11 | Issue 5 | Original Article | 633 | Copyright © May 2012
Objective: To quantify and compare the physiochemical properties of various topical emollients and to correlate these findings with the products' potential to maintain the stratum corneum (SC) ...
Read MoreWhere Does Rituximab Fit in the Treatment of Autoimmune Mucocutaneous Blistering Skin Disease?
May 2012 | Volume 11 | Issue 5 | Original Article | 622 | Copyright © May 2012
We propose rituximab as a first-line therapy for pemphigus vulgaris and steroid-dependent bullous pemphigoid with or without systemic steroids. A brief review of the literature substantiates the signi...
Read MoreTop Dermatologic Conditions in Patients of Color: An Analysis of Nationally Representative Data
April 2012 | Volume 11 | Issue 4 | Original Article | 466 | Copyright © April 2012
Background: Some dermatologic disorders are known to be much more common in patients of color, but the leading de...
Read More